Actual Medicinal Product (AMP) - Rybrevant 2240mg/14ml solution for injection vials (Janssen-Cilag Ltd)
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Current Name | Rybrevant 2240mg/14ml solution for injection vials | 28-07-2025 | |
Summary
- Licensed Route
- Subcutaneous
- Availability Restrictions
- None
- Licensing Authority
- Medicines - MHRA/EMA
- EMA Indicator
- EMA Monitoring
Codes
| Code | Start Date | End Date |
|---|---|---|
| 45346311000001105 | 28-07-2025 |
Parent Products
-
VTMAmivantamab
-
VMPAmivantamab 2.24g/14ml solution for injection v...
-
AMP(Current) Rybrevant 2240mg/14ml solution...
-
-
Actual Medicinal Product Pack (AMPP) Information
| Pack Size | Indicative Price | Discontinued |
|---|---|---|
| 1 vial | 431600 |